Icotinib, an EGFR tyrosine kinase inhibitor, as adjuvant therapy for patients with stage IIA-IIIA EGFR-mutant non-small-cell lung adenocarcinoma: a multicenter, open-label, single-arm, phase II study (ICAPE).
Saved in:
| Title: | Icotinib, an EGFR tyrosine kinase inhibitor, as adjuvant therapy for patients with stage IIA-IIIA EGFR-mutant non-small-cell lung adenocarcinoma: a multicenter, open-label, single-arm, phase II study (ICAPE). |
|---|---|
| Authors: | Qian K; Department of Thoracic Surgery, Xuanwu Hospital, Capital Medical University, No. 45, Changchun Street, Xicheng District, 100053, Beijing, China., Chen QR; Department of Thoracic Surgery, Beijing Institute of Respiratory Medicine and Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China., He M; Department of Thoracic Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China., Wang ZT; Department of Thoracic Surgery, Beijing Chest Hospital, Capital Medical University, Beijing, China., Liu Y; Second Department of Thoracic Surgery, Handan Central Hospital, East District, Handan, Hebei, China., Liang HG; Department of Thoracic Surgery, The First Hospital of Qinhuangdao, Qinhuangdao, Hebei, China., Su ZY; Department of Thoracic Surgery, Affiliated Hospital of Chifeng University, Chifeng, Neimenggu, China., Cui YS; Department of Thoracic Surgery, Peking Union Medical College Hospital, Beijing, China., Liu LJ; Department of Thoracic Surgery, Hebei Province People's Hospital, Shijiazhuang, Hebei, China., Zhang Y; Department of Thoracic Surgery, Xuanwu Hospital, Capital Medical University, No. 45, Changchun Street, Xicheng District, 100053, Beijing, China. xuanwuhosp@163.com. |
| Source: | Investigational new drugs [Invest New Drugs] 2023 Feb; Vol. 41 (1), pp. 44-52. Date of Electronic Publication: 2022 Nov 10. |
| Publication Type: | Clinical Trial, Phase II; Multicenter Study; Journal Article |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 8309330 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-0646 (Electronic) Linking ISSN: 01676997 NLM ISO Abbreviation: Invest New Drugs Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1573-0646 |
|---|---|
| DOI: | 10.1007/s10637-022-01316-5 |
